• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[抗 GP IIb/IIIa 和抗 CD9 单克隆抗体对人血小板 Ca2+ 通量的诱导作用]

[Induction of human platelet Ca2+ fluxes by anti-GP IIb/IIIa and anti-CD9 monoclonal antibodies].

作者信息

Wang M

机构信息

Institute of Hematology, CAMS, Tianjin.

出版信息

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1993 Oct;15(5):339-42.

PMID:8168216
Abstract

Calcium plays a central role in platelet activation. Calcium changes in acquorin-loaded human platelets induced by monoclonal antibodies (McAbs) were recorded using a PIGA-apparatus. McAb Apt4 is specific for GP IIb/IIIa and McAb XW-1 and SJ-9A4 are directed against CD9 antigen. All three McAbs were shown to elicit a Ca2+ rise in aequorin-loaded platelets. This rise was the sole result of Ca2+ influx in the case of Apt4 and XW-1 and of both Ca2+ influx and mobilization in the case of SJ-9A4. Platelet Ca2+ fluxes and aggregation induced by the three McAbs were inhibited by an anti-GP IIb/IIIa McAb HIP8. The Ca2+ channel blocker vorapamil exerted a complete inhibitory effect on platelet Ca2+ fluxes and aggregation induced by Apt4, and had a partial effect on that induced by XW-1 and SJ-9A4. The ADP inhibitor CP/CPK had a partial inhibitory effect on platelet Ca2+ fluxes and aggregation induced by Apt4 and XW-1, and a smal effect on that induced by SJ-9A4. The effects of the three McAbs were inhibited partially by the calmodulin inhibitor EBB. The results indicate that platelet Ca2+ fluxes induced by these three McAbs depend on different pathways.

摘要

钙在血小板激活过程中起着核心作用。使用PIGA仪器记录了单克隆抗体(McAbs)诱导的水母发光蛋白负载的人血小板中的钙变化。单克隆抗体Apt4对糖蛋白IIb/IIIa具有特异性,单克隆抗体XW-1和SJ-9A4针对CD9抗原。所有这三种单克隆抗体均显示可引起水母发光蛋白负载的血小板中Ca2+升高。在Apt4和XW-1的情况下,这种升高是Ca2+内流的唯一结果,而在SJ-9A4的情况下,是Ca2+内流和动员两者的结果。三种单克隆抗体诱导的血小板Ca2+通量和聚集受到抗糖蛋白IIb/IIIa单克隆抗体HIP8的抑制。钙通道阻滞剂维拉帕米对Apt4诱导的血小板Ca2+通量和聚集发挥完全抑制作用,对XW-1和SJ-9A4诱导的作用有部分影响。ADP抑制剂CP/CPK对Apt4和XW-1诱导的血小板Ca2+通量和聚集有部分抑制作用,对SJ-9A4诱导的作用有轻微影响。钙调蛋白抑制剂EBB对这三种单克隆抗体的作用有部分抑制作用。结果表明,这三种单克隆抗体诱导的血小板Ca2+通量取决于不同的途径。

相似文献

1
[Induction of human platelet Ca2+ fluxes by anti-GP IIb/IIIa and anti-CD9 monoclonal antibodies].[抗 GP IIb/IIIa 和抗 CD9 单克隆抗体对人血小板 Ca2+ 通量的诱导作用]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1993 Oct;15(5):339-42.
2
[Characterization of platelet activation induced by CD9 McAbs].[CD9单克隆抗体诱导的血小板活化的特征]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1995 Oct;17(5):365-70.
3
[Production and application of anti-human platelet GP IIb/IIIa monoclonal antibodies].抗人血小板糖蛋白IIb/IIIa单克隆抗体的制备与应用
Zhonghua Yi Xue Za Zhi. 1989 Aug;69(8):427-30, 30.
4
[Effects of McAbs HIP2, APT4 and HI117 on the human platelet cytoskeleton].[单克隆抗体HIP2、APT4和HI117对人血小板细胞骨架的影响]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1992 Feb;14(1):1-5.
5
Induction of platelet Ca2+ influx and mobilization by a monoclonal antibody to CD9 antigen.抗CD9抗原单克隆抗体诱导血小板Ca2+内流和动员
Blood. 1990 Mar 1;75(5):1087-91.
6
[Characteristics of human platelet fibrinogen receptors regulated by anti-CD9 monoclonal antibodies].[抗CD9单克隆抗体调控的人血小板纤维蛋白原受体特性]
Zhonghua Xue Ye Xue Za Zhi. 1999 Sep;20(9):456-8.
7
The activation of human platelets mediated by two monoclonal antibodies raised against CD9.由两种针对CD9产生的单克隆抗体介导的人血小板激活。
Thromb Res. 1997 Jul 1;87(1):65-73. doi: 10.1016/s0049-3848(97)00105-9.
8
The activation of human platelets mediated by anti-human platelet p24/CD9 monoclonal antibodies.抗人血小板p24/CD9单克隆抗体介导的人血小板激活。
J Biol Chem. 1990 Mar 5;265(7):3815-22.
9
Exposure of platelet fibrinogen receptors by a monoclonal antibody to CD9 antigen.用抗CD9抗原单克隆抗体暴露血小板纤维蛋白原受体。
Blood. 1988 Jul;72(1):224-9.
10
Ca2+ influx mediated through the GPIIb/IIIa complex during platelet activation.血小板激活过程中通过糖蛋白IIb/IIIa复合物介导的钙离子内流。
FEBS Lett. 1987 Dec 10;225(1-2):228-32. doi: 10.1016/0014-5793(87)81163-8.